Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Each week we present you with a featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates…
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related…
Administering two types of immunotherapy drugs concurrently has paused or reversed malignant tumor growth in almost sixty percent of patients participating in a UK clinical trial.
Edmond J. LaVoie, PhD, Professor and Chair of the Department of Medicinal Chemistry at Rutgers University, discusses the potential of a new antibiotic to combat the increasing problems…
MIT demonstrates the "origami robot" - measuring just one-centimeter in length and controlled via magnetic-field manipulation, this tiny bot will dissolve in liquid when its useful life has…
Rebecca Kaltman, MD, feeling frustrated with the limitations and shortcomings of a traditional medical practice, decided to found Breast Cancer Consultants – an online, direct-to-patient, breast cancer consultation…
Patients that have been diagnosed with breast cancer often end up with a cumbersome amount of appointments with their physicians and specialists. Many of these doctor visits could…
Incorporating elements of telemedicine into a traditional practice can improve a physician’s work-life balance while simultaneously improving their patients’ experiences. There are many patient appointments that don’t necessarily…
John Papandrea, CEO of Willowglade Technologies, discusses some of the major frustrations breast cancer sufferers experience aside from their actual diagnosis. Willowglade has recently created a smartphone application…
